Aegon’s McPartlin: Three stocks driving the paradigm shift in healthcare
Exciting developments are underway in the healthcare world, and these three companies are leading that change
healthcare stocks
-
-
AllianceBernstein: Investors are getting ahead of themselves about healthcare
Antidiabetic drugs such as Ozempic have markets excited about healthcare, but AllianceBernstein’s Vinay Thapar calls for caution amongst the hype
-
Janus Henderson rolls out global life sciences fund
The new offering aims to outperform the MSCI World Health Care Index
-
Branching Out: Polar Capital’s Donnigan on why ordering pizza is more reliable than getting biopsy results
Polar Capital’s Deane Donnigan tells Portfolio Adviser how she moved from clinical pharmacist to fund manager
